Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,065 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A postoperative body weight increase is a novel risk factor for incisional hernia of midline abdominal incision after elective gastroenterological surgery.
Mizusawa Y, Noda H, Ichida K, Fukai S, Matsuzawa N, Tamaki S, Abe I, Endo Y, Fukui T, Takayama Y, Inoue K, Muto Y, Watanabe F, Miyakura Y, Rikiyama T. Mizusawa Y, et al. Among authors: fukui t. Langenbecks Arch Surg. 2023 Nov 30;408(1):452. doi: 10.1007/s00423-023-03193-9. Langenbecks Arch Surg. 2023. PMID: 38032404 Clinical Trial.
Aqueous Povidone-Iodine Versus Normal Saline For Intraoperative Wound Irrigation on The Incidence of Surgical Site Infection in Clean-Contaminated Wounds After Gastroenterological Surgery: A Single-Institute, Prospective, Blinded-Endpoint, Randomized Controlled Trial.
Maemoto R, Noda H, Ichida K, Miyakura Y, Kakizawa N, Machida E, Aizawa H, Kato T, Iseki M, Fukui T, Muto Y, Fukai S, Tsujinaka S, Hatsuzawa Y, Watanabe F, Nagamori M, Takahashi J, Kimura Y, Maeda S, Takayama N, Sakio R, Takahashi R, Takenami T, Matsuzawa N, Mieno M, Rikiyama T. Maemoto R, et al. Among authors: fukui t. Ann Surg. 2023 May 1;277(5):727-733. doi: 10.1097/SLA.0000000000005786. Epub 2022 Dec 20. Ann Surg. 2023. PMID: 36538622 Clinical Trial.
Superiority trial for the development of an ideal method for the closure of midline abdominal wall incisions to reduce the incidence of wound complications after elective gastroenterological surgery: study protocol for a randomized controlled trial.
Fukai S, Mizusawa Y, Noda H, Tsujinaka S, Maeda Y, Hasebe R, Eguchi Y, Kanemitsu R, Matsuzawa N, Abe I, Endo Y, Fukui T, Takayama Y, Ichida K, Inoue K, Muto Y, Watanabe F, Futsuhara K, Miyakura Y, Rikiyama T. Fukai S, et al. Among authors: fukui t. Trials. 2024 May 17;25(1):327. doi: 10.1186/s13063-024-08167-w. Trials. 2024. PMID: 38760769 Free PMC article.
XELIRI regimen plus continuous treatment with bevacizumab is well-tolerated and effective in metastatic colorectal cancer patients in a second-line setting involving the sequential administration of XELOX and XELIRI.
Suzuki K, Takaharu K, Muto Y, Ichida K, Fukui T, Takayama Y, Tsujinaka S, Sasaki J, Horie H, Kawamura YJ, Konishi F, Rikiyama T. Suzuki K, et al. Among authors: fukui t. Mol Clin Oncol. 2014 Sep;2(5):827-832. doi: 10.3892/mco.2014.306. Epub 2014 Jun 6. Mol Clin Oncol. 2014. PMID: 25054053 Free PMC article.
Clinical and molecular assessment of regorafenib monotherapy.
Kakizawa N, Suzuki K, Fukui T, Takayama Y, Ichida K, Muto Y, Hasegawa F, Watanabe F, Kikugawa R, Tsujinaka S, Futsuhara K, Miyakura Y, Noda H, Rikiyama T. Kakizawa N, et al. Among authors: fukui t. Oncol Rep. 2017 Apr;37(4):2506-2512. doi: 10.3892/or.2017.5456. Epub 2017 Feb 15. Oncol Rep. 2017. PMID: 28259999
2,065 results